Cellenkos

Cellenkos

Biotechnology, 5416 Chaucer Dr, Houston, Texas, 77005, United States, 11-50 Employees

cellenkosinc.com

  • LinkedIn

phone no Phone Number: 83********

Who is CELLENKOS

Cellenkos is an early stage clinical biotechnology company that focuses on umbilical cord blood derived T-regulatory cellular therapies for treating autoimmune diseases and inflammatory d...

Read More

map
  • 5416 Chaucer Dr, Houston, Texas, 77005, United States Headquarters: 5416 Chaucer Dr, Houston, Texas, 77005, United States
  • 2016 Date Founded: 2016
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from CELLENKOS

Cellenkos Org Chart and Mapping

Employees

Monica Avila

Senior Director-CMC Alliance and Project Management

Sarah Champlin

Manager of Quality Control and Materials Management

Tara Sadeghi

Chief Operating Officer

Charisse Ayuste

Process Development and Marketing

Claudia Garza-Gonzalez

Clinical Manufacturing QA and Regulatory Manager

Aurash Javidinejad

Clinical Trial Management System & Data Systems Manager

Rachelle Espinosa

Clinical Manufacturing Manager

Hadley Flessner

Administrative Consultant

Megan Abella

Administrative Assistant

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Cellenkos

Answer: Cellenkos's headquarters are located at 5416 Chaucer Dr, Houston, Texas, 77005, United States

Answer: Cellenkos's phone number is 83********

Answer: Cellenkos's official website is https://cellenkosinc.com

Answer: Cellenkos's revenue is $1 Million to $5 Million

Answer: Cellenkos's SIC: 2834

Answer: Cellenkos's NAICS: 325412

Answer: Cellenkos has 11-50 employees

Answer: Cellenkos is in Biotechnology

Answer: Cellenkos contact info: Phone number: 83******** Website: https://cellenkosinc.com

Answer: Cellenkos is an early stage clinical biotechnology company that focuses on umbilical cord blood derived T-regulatory cellular therapies for treating autoimmune diseases and inflammatory disorders.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access